Lille, France

Michel Joseph

This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Joseph. Retrieved from https://idiyas.com/inventor/michel-joseph-2z0qnfgp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Joseph: Innovator in Lymphokine Research

Introduction

Michel Joseph is a notable inventor based in Lille, France. He has made significant contributions to the field of medical research, particularly in the area of lymphokines. His work has implications for understanding and managing platelet activation, which is crucial in various medical conditions.

Latest Patents

Michel Joseph holds a patent for a "Novel lymphokine for suppressing platelet activation." This innovation showcases his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Throughout his career, Michel has worked with prestigious institutions such as the Institut Pasteur de Lille and the Institut National de la Santé et de la Recherche Médicale. His roles in these organizations have allowed him to engage in groundbreaking research and development.

Collaborations

Michel has collaborated with esteemed colleagues, including André Capron and Véronique Pancre. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Michel Joseph's innovative work in lymphokine research exemplifies the importance of scientific inquiry in medicine. His contributions continue to influence the understanding of platelet activation and its implications for health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…